3 key account manager jobs found

National Account Manager –Government & GPO Who We Are Essity is a global leader in health and hygiene with our corporate headquarters in Stockholm, Sweden, and North American headquarters in Philadelphia, PA. We are a multi-billion-dollar company that is committed to breaking barriers to well-being. Essity does this through innovative brands in the areas of Professional Hygiene, Consumer Goods, and Health & Medical Solutions. Working at Essity is not just a career; it is a chance to directly make the world a healthier, more hygienic and safer place. With impactful innovations coupled with sustainable solutions, we strive to reach more people every year with the necessary and essential solutions for well-being. At Essity you will find a caring and compassionate culture where we remain grounded in our beliefs & behaviors. About the Role Essity’s Health and Medical team is seeking an experienced National Account Manager focused for leading the...

In this role, you will be at the forefront of developing and implementing innovative contract models tailored to our diversified oncology portfolio. You will build and maintain long-term business relationships with key stakeholders, specifically in the hospital, GPO, and wholesale segment, analyze market trends, and provide strategic input to drive our business forward. A typical day might include the following: Negotiation and conclusion of contracts primarily with hospitals, purchasing groups (GPO), and regional and national health insurance funds across Germany. Developing and implementing innovative contract models tailored to our oncology portfolio. Establishing and maintaining long-term business relationships with key stakeholders in the healthcare sector. Analysis and evaluation of market trends and competitive activities to optimize negotiation strategies. Development of education and training concepts for the internal Commercial team as well as external...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...